Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: A randomized controlled study

Journal of Internal Medicine

Volumn 250, Issue 2, 2001, Pages 144-153

  Rejnmark, L ^a,c   Vestergaard, P ^a,b   Heickendorff, L ^a   Andreasen, F ^b   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Biological markers; Bone; Calcitriol; Diuretics; Human; Parathyroid hormones

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BENDROFLUMETHIAZIDE; BUMETANIDE; CALCIUM; CREATININE; LOOP DIURETIC AGENT; OSTEOCALCIN; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME BLOOD LEVEL; FEMALE; HUMAN; KIDNEY TUBULE ABSORPTION; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION;

AGED; BENDROFLUMETHIAZIDE; BIOLOGICAL MARKERS; BONE AND BONES; BUMETANIDE; CALCITRIOL; DIURETICS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PARATHYROID HORMONE; RESEARCH DESIGN; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0034823482     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00868.x     Document Type: Article

References (35)

1. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis
2. Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism
3. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial
4. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial
5. Hyperparathyrodism in idiopathic hypercalciuria: Primary or secondary?
6. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms
7. Thiazide diuretics and calcium metabolism
8. Evidence for secondary hyperparathyrodism in idiopatic hypercalciuria
9. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones
10. Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females
11. The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women
12. Comparative effects of nitrendipine and hydrochlorothiazide on calcitropic hormones and bone density in hypertensive patients
13. A longitudinal study of total and regional bone mineral content and biochemical markers of bone resorption in patients with idiopathic hypercalciuria on thiazide treatment
14. A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women
15. Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women
16. Diuretic drug use and the risk for hip fracture
17. Thiazide diuretics and fractures: Can meta-analysis help?
18. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment
19. Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide
20. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis
21. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations
22. Benecial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria
23. Double-blind study with thiazide in recurrent calcium lithiasis
24. Direct tubular effect on calcium retention by hydrochlorothiazide
25. Subacute effects of thiazide administration on renal hemodynamics and calcium metabolism
26. Actions of thiazide on vitamin D metabolism: A controlled therapeutic trial in normal women early in the postmenopause
27. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide
28. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency
29. Effects of oral furosemide and salt loading on parathyroid function in normal subjects
30. The assessment of phosphate reabsorption
31. Tubular reabsorption of calcium in the differential diagnosis of hypercalcaemia. Further experience
32. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies
33. A specic immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
34. The effects of thiazides in idiopathic hypercalciuria
35. The effect of bendroflumethiazide on the intestinal absorption of calcium in normocalcaemic renal stone formers and in hyperparathyrodism